Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in young women in France: A population-based case-control study

American Journal of Epidemiology

Volumn 180, Issue 10, 2014, Pages 1007-1017

  Xhaard, Constance ^a,b   Rubino, Carole ^a,b   Cléro, Enora ^a,b   Maillard, Stéphane ^a,b   Ren, Yan ^a   Borson Chazot, Françoise ^c   Sassolas, Geneviève ^d   Schvartz, Claire ^e   Colonna, Marc ^f   Lacour, Brigitte ^g   Danzon, Arlette ^h   Velten, Michel ⁱ   Buemi, Antoine ^j   Bailly, Laurent ^k   Barjoan, Eugènia Mariné ^k   Schlumberger, Martin ^a   Orgiazzi, Jacques ^c   Adjadj, Elisabeth ^a,b   De Vathaire, Florent ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ DE LYON   (France)

^e INSTITUT JEAN GODINOT   (France)

^f Cancer Registry of Isère   (France)

^g UNIVERSITY HOSPITAL OF NANCY   (France)

^h UNIVERSITÉ DE FRANCHE COMTÉ   (France)

ⁱ UNIVERSITÉ DE STRASBOURG   (France)

^j Cancer Registry of Haut Rhin   (France)

^k UNIVERSITY HOSPITAL OF NICE   (France)

more..

Author keywords

Menstruation; Oral contraception; Pregnancy; Se control study; Thyroid cancer

Indexed keywords

CANCER; DIABETES; HEALTH RISK; HISTOPATHOLOGY; HORMONE; LACTATION; NUCLEAR POWER PLANT; POPULATION STRUCTURE; PREGNANCY; REPRODUCTIVE HEALTH; WOMENS HEALTH;

ABORTION; ADOLESCENT; ADULT; ARTICLE; BREAST FEEDING; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; FEMALE; FRANCE; HISTOPATHOLOGY; HUMAN; INTERVIEW; LACTATION; MAJOR CLINICAL STUDY; MALE; MENARCHE; MENSTRUAL IRREGULARITY; MENSTRUATION; ORAL CONTRACEPTIVE USE; POPULATION BASED CASE CONTROL STUDY; PREGNANCY DIABETES MELLITUS; PRIMIGRAVIDA; REPRODUCTION; RISK ASSESSMENT; SPONTANEOUS ABORTION; THYROID PAPILLARY CARCINOMA; CARCINOMA; CARCINOMA, PAPILLARY; CASE CONTROL STUDY; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; INCIDENCE; PREGNANCY; REPRODUCTIVE HISTORY; RISK FACTOR; THYROID NEOPLASMS;

FRANCE;

ESTROGEN;

ADULT; CARCINOMA; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; ENVIRONMENTAL EXPOSURE; ESTROGENS; FEMALE; FRANCE; HUMANS; INCIDENCE; MENARCHE; PREGNANCY; REPRODUCTIVE HISTORY; RISK FACTORS; THYROID NEOPLASMS;

EID: 84911381934     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu220     Document Type: Article

References (49)

1. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res. 1995;141(3):259-277.
2. Sinnott B, Ron E, Schneider AB. Exposing the thyroid to radiation: a review of its current extent, risks, and implications. Endocr Rev. 2010;31(5):756-773.
3. Brindel P, Doyon F, Rachédi F, et al. Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control. 2009;20(5):581-590.
4. Cléro E, Leux C, Brindel P, et al. Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid. 2010;20(11):1285-1293.
5. Dal Maso L, La Vecchia C, Franceschi S, et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control. 2000;11(2):137-144.
6. Engeland A, Tretli S, Akslen LA, et al. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer. 2006;95(3):366-370.
7. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS One. 2012;7(1):e29177.
8. Brindel P, Doyon F, Bourgain C, et al. Family history of thyroid cancer and the risk of differentiated thyroid cancer in French Polynesia. Thyroid. 2010;20(4):393-400.
9. Xu L, Li G, Wei Q, et al. Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer. 2012; 118(5):1228-1235.
10. Galanti MR, Hansson L, Lund E, et al. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1996;5(6):425-431.
11. Guignard R, Truong T, Rougier Y, et al. Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol. 2007;166(10): 1140-1149.
12. Kitahara CM, Linet MS, Beane Freeman LE, et al. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control. 2012;23(10):1615-1624.
13. Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2009;20(5):525-531.
14. Köhler A, Chen B, Gemignani F, et al. Genome-wide association study on differentiated thyroid cancer. J Clin Endocrinol Metab. 2013;98(10):E1674-E1681.
15. Damiola F, Byrnes G, Moissonnier M, et al. Contribution of ATM and FOXE1 (TTF2) to risk of papillary thyroid carcinoma in Belarusian children exposed to radiation. Int J Cancer. 2014; 134(7):1659-1668.
16. Bonora E, Rizzato C, Diquigiovanni C, et al. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma. Int J Cancer. 2014;134(9):2098-2107.
17. Wang YL, Feng SH, Guo SC, et al. Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population. J Med Genet. 2013;50(10): 689-695.
18. Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol. 2010;6(11):1771-1779.
19. Mack WJ, Preston-Martin S, Bernstein L, et al. Reproductive and hormonal risk factors for thyroid cancer in Los Angeles County females. Cancer Epidemiol Biomarkers Prev. 1999; 8(11):991-997.
20. Iribarren C, Haselkorn T, Tekawa IS, et al. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001;93(5):745-750.
21. Truong T, Orsi L, Dubourdieu D, et al. Role of goiter and of menstrual and reproductive factors in thyroid cancer: a population-based case-control study in New Caledonia (South Pacific), a very high incidence area. Am J Epidemiol. 2005; 161(11):1056-1065.
22. Bleyer A, Viny A, Barr R. Cancer in 15-to 29-year-olds by primary site. Oncologist. 2006;11(6):590-601.
23. Negri E, Dal Maso L, Ron E, et al. A pooled analysis of case-control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control. 1999;10(2): 143-155.
24. La Vecchia C, Ron E, Franceschi S, et al. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control. 1999;10(2):157-166.
25. Brindel P, Doyon F, Rachédi F, et al. Menstrual and reproductive factors in the risk of differentiated thyroid carcinoma in native women in French Polynesia: a population-based case-control study. Am J Epidemiol. 2008; 167(2):219-229.
26. Horn-Ross PL, Canchola AJ, Ma H, et al. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev. 2011;20(8): 1751-1759.
27. Schonfeld SJ, Ron E, Kitahara CM, et al. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiol. 2011;35(6):e85-e90.
28. Stsjazhko VA, Tsyb AF, Tronko ND, et al. Childhood thyroid cancer since accident at Chernobyl. BMJ. 1995; 310(6982):801.
29. Cardis E, Krewski D, Boniol M, et al. Estimates of the cancer burden in Europe from radioactive fallout from the Chernobyl accident. Int J Cancer. 2006;119(6):1224-1235.
30. Bailly L, Giusiano B, Barjoan EM, et al. Investigating the completeness of a histopathological cancer registry: estimation by capture-recapture analysis in a French geographical unit Alpes-Maritimes, 2008. Cancer Epidemiol. 2011;35(6): e62-e68.
31. Bailly L, Mariné-Barjoan E, Ambrosetti D, et al. Data quality of cancer registration by Adicap codes, used by French pathologists from Paca, 2005-2006. Ann Pathol. 2009;29(2): 74-79.
32. Colonna M, Bossard N, Guizard AV, et al. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol (Paris). 2010;71(2):95-101.
33. Zivaljevic VR, Vlajinac HD, Marinkovic JM, et al. Case-control study of anaplastic thyroid cancer: goiter patients as controls. Eur J Cancer Prev. 2008;17(2):111-115.
34. Sakoda LC, Horn-Ross PL. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Cancer Epidemiol Biomarkers Prev. 2002;11(1):51-57.
35. Preston-Martin S, Jin F, Duda MJ, et al. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control. 1993;4(5): 431-440.
36. Wong EY, Ray R, Gao DL, et al. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health. 2006;79(3):251-258.
37. Pham TM, Fujino Y, Mikami H, et al. Reproductive and menstrual factors and thyroid cancer among Japanese women: the Japan Collaborative Cohort Study. J Womens Health (Larchmt). 2009;18(3):331-335.
38. Sungwalee W, Vatanasapt P, Kamsa-Ard S, et al. Reproductive risk factors for thyroid cancer: a prospective cohort study in Khon Kaen, Thailand. Asian Pac J Cancer Prev. 2013;14(9): 5153-5155.
39. Rossing MA, Voigt LF, Wicklund KG, et al. Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol. 2000;151(8):765-772.
40. Kabat GC, Kim MY, Wactawski-Wende J, et al. Menstrual and reproductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control. 2012;23(12):2031-2040.
41. Memon A, Darif M, Al-Saleh K, et al. Epidemiology of reproductive and hormonal factors in thyroid cancer: evidence from a case-control study in the Middle East. Int J Cancer. 2002;97(1):82-89.
42. Hallquist A, Hardell L, Degerman A, et al. Thyroid cancer: reproductive factors, previous diseases, drug intake, family history and diet. A case-control study. Eur J Cancer Prev. 1994; 3(6):481-488.
43. Fiddes JC, Goodman HM. The gene encoding the common alpha subunit of the four human glycoprotein hormones. J Mol Appl Genet. 1981;1(1):3-18.
44. Zahid M, Goldner W, Beseler CL, et al. Unbalanced estrogen metabolism in thyroid cancer. Int J Cancer. 2013;133(11): 2642-2649.
45. Tafani M, De Santis E, Coppola L, et al. Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression. Biomed Pharmacother. 2014;68(1):1-5.
46. Sack J. Thyroid function in pregnancy-maternal-fetal relationship in health and disease. Pediatr Endocrinol Rev. 2003;1(Suppl 2):170-176.
47. Glinoer D, de Nayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab. 1990;71(2):276-287.
48. Manole D, Schildknecht B, Gosnell B, et al. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab. 2001;86(3):1072-1777.
49. de Vathaire F, Drozdovitch V, Brindel P, et al. Thyroid cancer following nuclear tests in French Polynesia. Br J Cancer. 2010; 103(7):1115-1121.